BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26705843)

  • 1. Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.
    Kumar RG; Rubin JE; Berger RP; Kochanek PM; Wagner AK
    Brain Behav Immun; 2016 Mar; 53():183-193. PubMed ID: 26705843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.
    Kumar RG; Diamond ML; Boles JA; Berger RP; Tisherman SA; Kochanek PM; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():253-62. PubMed ID: 25555531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
    Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.
    Santarsieri M; Niyonkuru C; McCullough EH; Dobos JA; Dixon CE; Berga SL; Wagner AK
    J Neurotrauma; 2014 Apr; 31(8):699-712. PubMed ID: 24354775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.
    Kumar RG; Boles JA; Wagner AK
    J Head Trauma Rehabil; 2015; 30(6):369-81. PubMed ID: 24901329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles.
    Failla MD; Conley YP; Wagner AK
    Neurorehabil Neural Repair; 2016 Jan; 30(1):83-93. PubMed ID: 25979196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury.
    Juengst SB; Kumar RG; Failla MD; Goyal A; Wagner AK
    J Head Trauma Rehabil; 2015; 30(3):207-18. PubMed ID: 24590155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of neuroinflammation in severe clinical traumatic brain injury.
    Vaughan LE; Ranganathan PR; Kumar RG; Wagner AK; Rubin JE
    J Neuroinflammation; 2018 Dec; 15(1):345. PubMed ID: 30563537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury.
    Vijapur SM; Vaughan LE; Awan N; DiSanto D; McKernan GP; Wagner AK
    Brain Behav Immun; 2021 Jul; 95():45-60. PubMed ID: 33524553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of a Combination of Circulating Biomarkers in Critically Ill Patients with Traumatic Brain Injury: Results from the European CREACTIVE Study.
    Gradisek P; Carrara G; Antiga L; Bottazzi B; Chieregato A; Csomos A; Fainardi E; Filekovic S; Fleming J; Hadjisavvas A; Kaps R; Kyprianou T; Latini R; Lazar I; Masson S; Mikaszewska-Sokolewicz M; Novelli D; Paci G; Xirouchaki N; Zanier E; Nattino G; Bertolini G;
    J Neurotrauma; 2021 Oct; 38(19):2667-2676. PubMed ID: 34235978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6-12 Month Global Outcomes.
    Rubenstein R; McQuillan L; Wang KKW; Robertson C; Chang B; Yang Z; Xu H; Williamson J; Wagner AK
    J Neurotrauma; 2024 Feb; 41(3-4):369-392. PubMed ID: 37725589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children.
    Chiaretti A; Antonelli A; Riccardi R; Genovese O; Pezzotti P; Di Rocco C; Tortorolo L; Piedimonte G
    Eur J Paediatr Neurol; 2008 May; 12(3):195-204. PubMed ID: 17881264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.
    Goyal A; Failla MD; Niyonkuru C; Amin K; Fabio A; Berger RP; Wagner AK
    J Neurotrauma; 2013 Jun; 30(11):946-57. PubMed ID: 23190274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury.
    Lee S; Hwang H; Yamal JM; Goodman JC; Aisiku IP; Gopinath S; Robertson CS
    J Neurosurg; 2019 Jan; 131(6):1931-1937. PubMed ID: 30641838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
    Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
    J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI.
    Failla MD; Juengst SB; Arenth PM; Wagner AK
    Neurorehabil Neural Repair; 2016 Jun; 30(5):419-30. PubMed ID: 26276123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.